Abstract
Studies have shown increased invasive Group A Streptococcus (GAS) disease, including bloodstream infections (GAS-BSI). However, the epidemiological data of GAS-BSI are limited in children. We aimed to describe GAS-BSI in children in Madrid, over 13 years (2005–2017). Multicenter retrospective cohort study from 16 hospitals from Madrid, Spain. Epidemiology, symptomatology, laboratory, treatment, and outcome of GAS-BSI in children ≤ 16 years were analyzed. 109 cases of GAS-BSI were included, with incidence rate of 4.3 episodes/100,000 children attended at the emergency department/year. We compared incidence between two periods (P1: 2005-June 2011 vs P2: July 2011–2017) and observed a non-significant increase along the study period (annual percentage change: + 6.0% [95%CI: -2.7, + 15.4]; p = 0.163). Median age was 24.1 months (IQR: 14.0–53.7), peaking during the first four years of life (89/109 cases; 81.6%). Primary BSI (46.8%), skin and soft tissue (21.1%), and osteoarticular infections (18.3%) were the most common syndromes. We compared children with primary BSI with those with a known source and observed that the former had shorter hospital stay (7 vs. 13 days; p = 0.003) and received intravenous antibiotics less frequently (72.5% vs. 94.8%; p = 0.001) and for shorter duration of total antibiotic therapy (10 vs. 21 days; p = 0.001). 22% of cases required PICU admission. Factors associated with severity were respiratory distress, pneumonia, thrombocytopenia, and surgery, but in multivariate analysis, only respiratory distress remained significant (adjusted OR:9.23 [95%CI: 2.16–29.41]). Two children (1.8%) died.
Conclusion: We observed an increasing, although non-significant, trend of GAS-BSI incidence within the study. Younger children were more frequently involved, and primary BSI was the most common and less severe syndrome. PICU admission was frequent, being respiratory distress the main risk factor.
What is known: • In recent decades, several reports have shown a worldwide increase in the incidence of invasive Group A streptococcal disease (GAS), including bloodstream infection (BSI). Recently, there have been a few reports showing an increase in severity as well. • There needs to be more information on the epidemiology in children since most studies predominantly include adults. | |
What is new: • This study, carried out in children with GAS-BSI in Madrid, shows that GAS-BSI affects mostly younger children, with a broad spectrum of manifestations, needing PICU admission frequently. Respiratory distress was the leading risk factor for severity, whereas primary BSI seemed to be less severe. • We observed an increasing, although non-significant, trend of GAS-BSI incidence in recent years (2005–2017). |
This is a preview of subscription content, log in via an institution to check access.
Availability of data and materials
All of the material is owned by the authors and is available for consultation if required.
Abbreviations
- APC:
-
Annual percentage change
- BSI:
-
Bloodstream infection
- GAS:
-
Group A Streptococcus or Streptococcus pyogenes
- iGAS:
-
Invasive infections caused by GAS
- IQR:
-
Interquartile range
- OR:
-
Odds ratio
- PICU:
-
Pediatric intensive care unit
References
Tapiainen T, Launonen S, Renko M, Saxen H, Salo E, Korppy M, Kainulainen L, Heiskanenkosma T, Lindholm L, Vuopio J et al (2016) Invasive Group A Streptococcal Infections in Children: A Nationwide Survey in Finland. Pediatr Infect Dis J 35(2):123–128. https://doi.org/10.1097/INF.0000000000000945
Espadas-Maciá D, Macián EMF, Borrás R, Poujois Gisbert S, Muñoz Bonet JI (2018) Streptococcus pyogenes infection in paediatrics: from pharyngotonsillitis to invasive infections. An Pediatr (Engl Ed) 88(2):75–81. https://doi.org/10.1016/j.anpedi.2017.02.011
Centers for Disease Control and Prevention (CDC) (2022) Increase in invasive group A strep infections. Atlanta: CDC. Available from: https://www.cdc.gov/groupastrep/igasinfectionsinvestigation.html#:~:text=CDC%20is%20looking%20into%20a,and%20streptococcal%20toxic%20shock%20syndrome
Guy R, Henderson KL, Coelho J, Hughes H, Mason EL, Gerver SM, Demirjian A, Watson C, Sharp A, Brown CS, Lamagni T (2023) Increase in invasive group A streptococcal infection notifications, England, 2022. Euro Surveill. https://doi.org/10.2807/1560-7917.ES.2023.28.1.2200942
Cobo-Vázquez E, Aguilera-Alonso D, Carrasco-Colom J, Calvo C, Saavedra-Lozano J, PedGAS-net Working Group (2023) Increasing incidence and severity of invasive group A streptococcal disease in Spanish children in 2019–2022. The Lancet Regional Health. Europe 27. https://doi.org/10.1016/j.lanepe.2023.100597
de Gier B, Marchal N, de Beer-Schuurman I, te Wierik M, Hooiveld M, de Melker HE, van Sorge NM, ISIS-AR Study Group, GAS Study group, Members of the ISIS-AR study group (2023) Increase in invasive group A streptococcal (Streptococcus pyogenes) infections (iGAS) in young children in the Netherlands, 2022. Euro Surveill 28(1):2200941. https://doi.org/10.2807/1560-7917.ES.2023.28.1.2200941
Suárez-Arrabal MC, Sánchez Cámara LA, Navarro Gómez ML, Santos Sebastián MDM, Hernández-Sampelayo T, Cercenado Mansilla E, Saavedra-Lozano J (2019) Invasive disease due to streptococcus pyogenes: changes in incidence and prognostic factors. An Pediatr 91(5):286–295. https://doi.org/10.1016/j.anpedi.2018.12.017
Montes M, Ardanuy C, Tamayo E, Domènech A, Liñares J, Pérez-Trallero E (2011) Epidemiological and molecular analysis of Streptococcus pyogenes isolates causing invasive disease in Spain (1998–2009): comparison with non-invasive isolates. Eur J Clin Microbiol Infect Dis 30(10):1295–1302. https://doi.org/10.1007/s10096-011-1226-x
Nelson GE, Pondo T, Toews KA, Farley MM, Lindegren ML, Lynfiedl R, Aragon D, Zansky SM, Watt JP, Cieslak PR et al (2016) Epidemiology of invasive group A streptococcal infections in the United States, 2005–2012. Clin Infect Dis 63(4):478–486. https://doi.org/10.1093/cid/ciw248
Meehan M, Murchan S, Gavin PJ, Drew RJ, Cunney R (2018) Epidemiology of an upsurge of invasive group A Streptococcal infections in Ireland, 2012–2015. J Infect 77(3):183–190. https://doi.org/10.1016/j.jinf.2018.05.010
Ching NS, Crawford N, McMinn A, Baker C, Azzopardi K, Brownlee K, Lee D, Gibson M, Smeesters P, Gonis G et al (2017) Prospective surveillance of pediatric invasive group a Streptococcus infection. J Pediatric Infect Dis Soc 8(1):46–52. https://doi.org/10.1093/jpids/pix099
Babiker A, Li X, Lay YL, Strich JR, Warner S, Sarzynski S, Dekker JP, Danner RL, Kadri SS (2021) Effectiveness of adjunctive clindamycin in β-lactam antibiotic-treated patients with invasive β-haemolytic streptococcal infections in US hospitals: a retrospective multicentre cohort study. Lancet Infect Dis 21(5):697–710. https://doi.org/10.1016/S1473-3099(20)30523-5
Author information
Authors and Affiliations
Contributions
All authors contributed to the study conception and design. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Ethical approval
This study was approved by the Ethics Committees of each participating center. As the case recruitment was conducted retrospectively, obtaining informed consent was deemed unnecessary. Competing interests.
Conflict of interest
The authors have no conflicts of interest relevant to this article to disclose.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Cobo-Vázquez, E., Aguilera-Alonso, D., Carbayo, T. et al. Epidemiology and clinical features of Streptococcus pyogenes bloodstream infections in children in Madrid, Spain. Eur J Pediatr 182, 3057–3062 (2023). https://doi.org/10.1007/s00431-023-04967-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00431-023-04967-5